Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nguyen, N. P.
Right arrow Articles by Sallah, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nguyen, N. P.
Right arrow Articles by Sallah, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 15:383-388, 2004
© 2004 European Society for Medical Oncology


Original Paper

Dysphagia following chemoradiation for locally advanced head and neck cancer

Received 29 May 2003; revised 3 November 2003; accepted 17 December 2003

Background:

To assess the prevalence, severity and morbidity of dysphagia following concurrent chemoradiation for head and neck cancer.

Patients and methods:

Patients who underwent chemotherapy and radiation for head and neck malignancies were evaluated for their ability to resume oral feeding following treatment. Modified barium swallow (MBS) studies were performed if the patients complained of dysphagia or if there was clinical suspicion of aspiration. The severity of dysphagia was graded on a scale of 1–7. If significant abnormalities were found, swallowing studies were repeated until resolution of dysphagia.

Results:

Between March 1999 and May 2002, 55 patients with locally advanced head and neck cancer underwent concurrent chemotherapy and radiation. Aspiration pneumonia was observed in eight patients, three during treatment and five following treatment. Five patients died from pneumonia. Two patients developed respiratory failure requiring intubation as a complication of pneumonia. At a median follow-up of 17 months (range 6–48 months), 25 patients (45%) developed severe dysphagia requiring prolonged tube feedings for more than 3 months (22 patients) or repeated dilatations (three patients). Among 33 patients who underwent MBS following treatment, 12 patients (36%) had silent aspiration (grade 6–7 dysphagia). Thirteen patients (39%) developed grade 4–5 dysphagia which required prolonged enteral nutritional support to supplement their oral intake. Most patients had severe weight loss (0–21 kg) during treatment, likely due in part to mucositis in the orodigestive tube.

Conclusions:

Dysphagia is a common, debilitating and potentially life-threatening sequela of concurrent chemoradiation for head and neck malignancy. Physicians should be aware that the clinical manifestations of aspiration may be unreliable and insidious, because of the depressed cough reflex. Modified and traditional barium swallows should be performed following treatment to assess the safety of oral feeding and the structural integrity of the pharynx and esophagus. Patients with severe dysphagia may benefit from rehabilitation. Tube feeding should be continued for those with aspiration.

N. P. Nguyen1,*, C. C. Moltz2, C. Frank2, P. Vos3, H. J. Smith4, U. Karlsson5, S. Dutta6, F. A. Midyett4, J. Barloon7 and S. Sallah8

1 Radiation Oncology, 2 Audiology and Speech Pathology, 4 Radiology and 7 Dietetics Services, VA North Texas Health Care System, Dallas, TX; Departments of 3 Biostatistics and 5 Radiation Oncology, East Carolina University, Greenville, NC; 6 Department of Radiation Oncology, Plano Cancer Center, Plano, TX; 8 Division of Hematology/Oncology, Louisiana State University, Shreveport, LA, USA

Key words: aspiration, chemoradiation, dysphagia, head and neck cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JCOHome page
J. A. Langendijk, P. Doornaert, I. M. Verdonck-de Leeuw, C. R. Leemans, N. K. Aaronson, and B. J. Slotman
Impact of Late Treatment-Related Toxicity on Quality of Life Among Patients With Head and Neck Cancer Treated With Radiotherapy
J. Clin. Oncol., August 1, 2008; 26(22): 3770 - 3776.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
P. M. Specenier, D. Van den Weyngaert, C. Van Laer, J. Weyler, J. Van den Brande, M. T. Huizing, J. Dyck, D. Schrijvers, and J. B. Vermorken
Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data
Ann. Onc., November 1, 2007; 18(11): 1856 - 1860.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. M. Bentzen and A. Trotti
Evaluation of Early and Late Toxicities in Chemoradiation Trials
J. Clin. Oncol., September 10, 2007; 25(26): 4096 - 4103.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
A. Raykher, L. Russo, M. Schattner, L. Schwartz, B. Scott, and M. Shike
Enteral Nutrition Support of Head and Neck Cancer Patients
Nutr Clin Pract, February 1, 2007; 22(1): 68 - 73.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. J. Herrera, A. M. Correa, A. A. Vaporciyan, W. L. Hofstetter, D. C. Rice, S. G. Swisher, G. L. Walsh, J. A. Roth, and R. J. Mehran
Increased Risk of Aspiration and Pulmonary Complications After Lung Resection in Head and Neck Cancer Patients
Ann. Thorac. Surg., December 1, 2006; 82(6): 1982 - 1988.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. G. Pfister, S. A. Laurie, G. S. Weinstein, W. M. Mendenhall, D. J. Adelstein, K. K. Ang, G. L. Clayman, S. G. Fisher, A. A. Forastiere, L. B. Harrison, et al.
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
J. Clin. Oncol., August 1, 2006; 24(22): 3693 - 3704.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. A. Bonner, P. M. Harari, J. Giralt, N. Azarnia, D. M. Shin, R. B. Cohen, C. U. Jones, R. Sur, D. Raben, J. Jassem, et al.
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
N. Engl. J. Med., February 9, 2006; 354(6): 567 - 578.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
T. Yamamoto, E. Ueta, T. Kamatani, and T. Osaki
DNA identification of the pathogen of candidal aspiration pneumonia induced in the course of oral cancer therapy
J. Med. Microbiol., May 1, 2005; 54(5): 493 - 496.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J.-L. Lefebvre
Current clinical outcomes demand new treatment options for SCCHN
Ann. Onc., January 1, 2005; 16(suppl_6): vi7 - vi12.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
A. Eisbruch
Dysphagia and aspiration following chemo-irradiation of head and neck cancer: major obstacles to intensification of therapy
Ann. Onc., March 1, 2004; 15(3): 363 - 364.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.